Bank Julius Baer & Co. Ltd Zurich Cuts Position in Intuitive Surgical, Inc. $ISRG

Bank Julius Baer & Co. Ltd Zurich decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.7% in the 2nd quarter, Holdings Channel reports. The firm owned 522,721 shares of the medical equipment provider’s stock after selling 62,614 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in Intuitive Surgical were worth $284,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norway Savings Bank increased its holdings in Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares in the last quarter. Trust Co. of Oklahoma acquired a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $363,000. IronOak Wealth LLC. purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $1,099,000. Amalgamated Bank raised its position in shares of Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares during the last quarter. Finally, Neville Rodie & Shaw Inc. lifted its stake in Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after buying an additional 1,110 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Royal Bank Of Canada set a $625.00 target price on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Finally, Daiwa Capital Markets raised their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $560.00, for a total transaction of $58,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 116,164 shares of company stock worth $61,916,172. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $561.61 on Monday. The firm’s 50-day simple moving average is $492.09 and its 200-day simple moving average is $503.90. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market cap of $201.32 billion, a P/E ratio of 74.29, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.84 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.